Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 238

1.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
2.

Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database.

Stiles ZE, Behrman SW, Glazer ES, Deneve JL, Dong L, Wan JY, Dickson PV.

HPB (Oxford). 2017 Jul 28. pii: S1365-182X(17)30853-5. doi: 10.1016/j.hpb.2017.06.012. [Epub ahead of print]

PMID:
28760630
3.

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage.

Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM Jr, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P 2nd, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, Ceppa EP, Abdel-Misih SRZ, Riall TS, Silberfein EJ, Ellison EC, Adams DB, Hsu C, Tran Cao HS, Mohammed S, VillafaƱe-Ferriol N, Barakat O, Massarweh NN, Chai C, Mendez-Reyes JE, Fang A, Jo E, Mo Q, Fisher WE.

Ann Surg. 2017 Sep;266(3):421-431. doi: 10.1097/SLA.0000000000002375.

PMID:
28692468
4.

Characterization and Optimal Management of High-Risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2017 Jun 7. doi: 10.1097/SLA.0000000000002327. [Epub ahead of print]

PMID:
28594741
5.

Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma.

Chavez MT, Sharpe JP, O'Brien T, Patton KT, Portnoy DC, VanderWalde NA, Deneve JL, Shibata D, Behrman SW, Dickson PV.

Am J Surg. 2017 Jan 30. pii: S0002-9610(16)31036-4. doi: 10.1016/j.amjsurg.2017.01.029. [Epub ahead of print]

PMID:
28285709
6.

Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?

Dolejs S, Zarzaur BL, Zyromski NJ, Pitt HA, Riall TS, Hall BL, Behrman SW.

J Gastrointest Surg. 2017 Apr;21(4):647-656. doi: 10.1007/s11605-017-3381-6. Epub 2017 Feb 15.

PMID:
28205125
7.

Diagnosing early cognitive decline-When, how and for whom?

Allan CL, Behrman S, Ebmeier KP, Valkanova V.

Maturitas. 2017 Feb;96:103-108. doi: 10.1016/j.maturitas.2016.11.018. Epub 2016 Dec 1. Review.

PMID:
28041588
8.

Patient safety in community dementia services: what can we learn from the experiences of caregivers and healthcare professionals?

Behrman S, Wilkinson P, Lloyd H, Vincent C.

Age Ageing. 2016 Dec 7. [Epub ahead of print]

PMID:
27932369
9.

Pancreas fistula risk prediction: implications for hospital costs and payments.

Abbott DE, Tzeng CW, McMillan MT, Callery MP, Kent TS, Christein JD, Behrman SW, Schauer DP, Hanseman DJ, Eckman MH, Vollmer CM.

HPB (Oxford). 2017 Feb;19(2):140-146. doi: 10.1016/j.hpb.2016.10.016. Epub 2016 Nov 21.

PMID:
27884544
10.

miRNA nanotherapeutics for cancer.

Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M.

Drug Discov Today. 2017 Feb;22(2):424-432. doi: 10.1016/j.drudis.2016.10.014. Epub 2016 Nov 1. Review.

PMID:
27815139
11.

Driving and dementia: a clinical update for mental health professionals.

Allan CL, Behrman S, Baruch N, Ebmeier KP.

Evid Based Ment Health. 2016 Nov;19(4):110-113. doi: 10.1136/eb-2016-102485. Epub 2016 Oct 20.

PMID:
27765792
12.

Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.

Weatherall T, Denbo J, Sharpe J, Martin M, O'Brien T, Gupta R, Groshart K, Behrman S, Dickson P.

World J Surg. 2017 Mar;41(3):844-850. doi: 10.1007/s00268-016-3770-0.

PMID:
27743074
13.

Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios.

McMillan MT, Ecker BL, Behrman SW, Callery MP, Christein JD, Drebin JA, Fraker DL, Kent TS, Lee MK, Roses RE, Sprys MH, Vollmer CM Jr.

J Gastrointest Surg. 2016 Dec;20(12):2052-2062. Epub 2016 Oct 11.

PMID:
27730401
14.

Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy.

Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC.

J Gastrointest Surg. 2017 Jan;21(1):94-105. doi: 10.1007/s11605-016-3222-z. Epub 2016 Aug 9.

PMID:
27507554
15.

MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.

Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB, Ise T, Nagata S, Zafar N, Behrman SW, Wan JY, Ghimire HM, Sahay P, Pradhan P, Chauhan SC, Jaggi M.

Oncogene. 2017 Jan 26;36(4):491-500. doi: 10.1038/onc.2016.218. Epub 2016 Jun 20.

16.

Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.

McMillan MT, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Fernandez-Del Castillo C, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares KC, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2017 May;265(5):978-986. doi: 10.1097/SLA.0000000000001796.

PMID:
27232260
17.

PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.

Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.

Colloids Surf B Biointerfaces. 2016 Aug 1;144:8-20. doi: 10.1016/j.colsurfb.2016.03.071. Epub 2016 Mar 26.

18.

Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.

McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Miller BC, Salem RR, Soares K, Valero V, Wolfgang CL, Vollmer CM Jr.

Ann Surg. 2016 Aug;264(2):344-52. doi: 10.1097/SLA.0000000000001537.

PMID:
26727086
19.

Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.

McMillan MT, Christein JD, Callery MP, Behrman SW, Drebin JA, Hollis RH, Kent TS, Miller BC, Sprys MH, Watkins AA, Strasberg SM, Vollmer CM Jr.

Surgery. 2016 Apr;159(4):1013-22. doi: 10.1016/j.surg.2015.10.028. Epub 2015 Dec 6.

PMID:
26670325
20.

Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms.

Gupta RK, Xie BH, Patton KT, Lisovsky M, Burks E, Behrman SW, Klimstra D, Deshpande V.

Hum Pathol. 2016 Feb;48:154-62. doi: 10.1016/j.humpath.2015.09.017. Epub 2015 Oct 3.

Supplemental Content

Loading ...
Support Center